Unicycive Therapeutics, Inc. (UNCY) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$6.5
Day's range
$7.11

Unicycive Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VIVO CAPITAL, LLC 02/13/2026 1.79 M $10.33 M   0.00% 9.91%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.01 M $5.86 M   100.00% 5.62%
OCTAGON CAPITAL ADVISORS LP 02/17/2026 1.00 M $5.77 M   0.00% 5.54%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/13/2026 939.20 K $5.42 M   0.00% 5.20%
GREAT POINT PARTNERS LLC 02/17/2026 796.56 K $4.60 M   0.00% 4.41%
VANGUARD GROUP INC 01/29/2026 788.59 K $4.55 M   19.69% 4.37%
LOGOS GLOBAL MANAGEMENT LP 02/17/2026 473.56 K $2.73 M   0.00% 2.62%
CITADEL ADVISORS LLC 02/17/2026 258.30 K $1.49 M   519.81% 1.43%
CANTOR FITZGERALD, L. P. 02/17/2026 200.00 K $1.15 M   100.00% 1.11%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 171.29 K $989.21 K   36.24% 0.95%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 99.74 K $575.51 K   181,249.09% 0.55%
DAUNTLESS INVESTMENT GROUP, LLC 02/17/2026 89.42 K $515.93 K   100.00% 0.50%
OMERS ADMINISTRATION CORP 02/13/2026 78.20 K $451.21 K   100.00% 0.43%
STATE STREET CORP 02/13/2026 65.23 K $376.36 K   18.97% 0.36%
ACUTA CAPITAL PARTNERS, LLC 02/17/2026 59.99 K $346.11 K   0.00% 0.33%
SQUAREPOINT OPS LLC 02/13/2026 55.31 K $319.11 K   -52.86% 0.31%
MORGAN STANLEY 02/13/2026 46.58 K $268.79 K   338.97% 0.26%
QUADRATURE CAPITAL LTD 02/17/2026 39.11 K $225.69 K   100.00% 0.22%
BLACKROCK, INC. 02/12/2026 36.36 K $209.77 K   0.00% 0.20%
NORTHERN TRUST CORP 02/17/2026 35.94 K $207.36 K   9.90% 0.20%
XTX TOPCO LTD 02/17/2026 35.41 K $204.29 K   -6.39% 0.20%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 26.30 K $151.75 K   100.00% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 24.93 K $143.85 K   100.00% 0.14%
CHICAGO PARTNERS INVESTMENT GROUP LLC 01/28/2026 22.41 K $155.10 K   -16.87% 0.12%
JANE STREET GROUP, LLC 02/12/2026 20.90 K $120.59 K   100.00% 0.12%
UBS GROUP AG 01/29/2026 19.91 K $114.85 K   265.56% 0.11%
CITADEL ADVISORS LLC 02/17/2026 10.90 K $62.89 K   100.00% 0.06%
TOWER RESEARCH CAPITAL LLC (TRC) 02/17/2026 1.92 K $11.08 K   100.00% 0.01%
SBI SECURITIES CO., LTD. 02/03/2026 558 $3.22 K   -0.36% 0.00%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 03/17/2026 500 $2.89 K   0.00% 0.00%
TFC FINANCIAL MANAGEMENT, INC. 01/23/2026 300 $1.73 K   0.00% 0.00%
CITIGROUP INC 02/13/2026 228 $1.32 K   -96.59% 0.00%
BANK OF AMERICA CORP /DE/ 02/17/2026 152 $877   -81.62% 0.00%
HARBOUR INVESTMENTS, INC. 02/09/2026 100 $577   0.00% 0.00%
BARCLAYS PLC 02/13/2026 80 $462   0.00% 0.00%
BOGART WEALTH, LLC 01/30/2026 6 $35   0.00% 0.00%
DANSKE BANK A/S 02/02/2026 1 $6   0.00% 0.00%
GOLDMAN SACHS GROUP INC 03/25/2026 0 $0   -100.00% 0.00%
FORTITUDE FAMILY OFFICE, LLC 01/15/2026 0 $0   -100.00% 0.00%

Unicycive Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 40 institutional investors and hedge funds held shares of Unicycive Therapeutics Inc. The most heavily invested institutionals were:

Chicago Partners Investment Group LLC: 21,778

UBS Group AG: 19,444

SBI Securities Co., Ltd.: 557

TFC Financial Management, Inc.: 300

Fortitude Family Office, LLC: 75

Bogart Wealth, LLC: 6

45.08% of Unicycive Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 8.26 M shares in the last 24 months. This purchase volume represents approximately $58.24 M in transactions.